VV ECMO Strategies for COVID-19, A Single Center Experience
Topics covered in this webinar included patient selection and management, cannulation preference, extracorporeal circuit design, staffing models and personal protective equipment.
Extracorporeal Membrane Oxygenation Support in Severe COVID-19
The early outcomes presented here suggest that the judicious use of ECMO support in severe COVID-19 may be clinically beneficial.
Utilization of Thromboelastogram and Inflammatory Markers in the Management of Hypercoagulable State in Patients with COVID-19 Requiring ECMO Support
The results of this case report show successful management of a hypercoagulable state among COVID-19 patients requiring ECMO support by utilization of inflammatory markers and TEG.
Observational Study of Thrombosis and Bleeding In COVID-19 VV ECMO Patients
We observed a high prevalence of VTE and a significant number of hemorrhages in these severely ill patients with COVID-19 requiring veno-venous ECMO support.
Extracorporeal Membrane Oxygenation Versus Mechanical Ventilation Alone in Adults with Severe Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
This study showed that the ECMO group exhibited a significantly lower mortality rate compared with the MV alone group at 90, 30 and 60 days for severe ARDS patients.
Thromboelastometry, Thromboelastography, and Conventional Tests to Assess Anticoagulation During Extracorporeal Support: A Prospective Observational Study
The aim of the study was to evaluate ROTEM as a tool for assessing hemostasis during ECMO, by comparing it to TEG and conventional coagulation assays.
The Hemovent Oxygenator: A New Low-Resistance, High-Performance Oxygenator
The aim of the current animal study was to evaluate the pressure gradient across the oxygenator and the gas exchange performance within a blood flow rate (BFR) range of 1–4 L/min, typically used in clinical practice for ECMO and ECCO2R.
Insight Into ECMO, Mortality and ARDS: A Nationwide Analysis of 45,647 ECMO Runs
ARDS is a severe disease with a high mortality rate despite ECLS therapy. Although endpoints and timing of the evaluations differed from those of the CESAR and EOLIA studies and the Extracorporeal Life Support Organization (ELSO) Registry, the reported mortality in these studies was lower than in the present analysis. Further prospective analyses are necessary to evaluate outcomes in ECMO therapy at the centre volume level.
Tidal Flow Perfusion for the Artificial Placenta: A Paradigm Shift
Parameters of the tidal flow group were comparable with those of DLC. Single lumen jugular cannulation using tidal flow is a promising vascular access strategy for AP support. Successful miniaturization holds great potential for clinical translation to support extremely premature infants.
Extubation during Extracorporeal Membrane Oxygenation in Adults: An International Qualitative Study on Experts’ Opinions
Highlights In all, 14 adult-ECMO experts participated in four focus groups and two interviews Seven themes were identified in this qualitative multidisciplinary […]
The Minnesota Mobile Extracorporeal Cardiopulmonary Resuscitation Consortium for Treatment of Out-Of-Hospital Refractory Ventricular Fibrillation: Program Description, Performance, and Outcomes
This first, community-wide ECMO-facilitated resuscitation program in the US demonstrated 100% successful cannulation, 43% functionally favorable survival rates at hospital discharge and 3 months, as well as safety. The program provides a potential model of this approach for other communities.
Membrane Lung and Blood Pump Use During Prolonged Extracorporeal Membrane Oxygenation
This manuscript describes the use of membrane lungs and blood pumps used during ECLS support from 2002 to 2017 in over 65,000 patients reported to the Extracorporeal Life Support Organization Registry. Device longevity and complications associated with membrane lungs and blood pump are described and stratified by age group: neonates, pediatrics, and adults.